Common adverse effects include gastrointestinal symptoms such as nausea, vomiting, diarrhea, and constipation, typically most pronounced during dose escalation
The lipid-lowering effects of GLP-1 medications appear to be mediated through several mechanisms: Weight loss : Reduction in body weight and visceral adiposity improves insulin sensitivity and hepatic lipid metabolism Improved glycemic control : Better glucose regulation reduces hepatic very-low-density lipoprotein (VLDL) production Potential hepatic effects : Some evidence suggests GLP-1 signaling may influence lipid metabolism, though human data are limited Reduced postprandial lipemia : Delayed gastric emptying decreases triglyceride excursions after meals It is important to note that GLP-1 receptor agonists should not be considered primary lipid-lowering agents
These findings provide evidence that the regulatory influence of endogenous GLP-1R signaling on bone resorption is likely mediated through pathways that involve calcitonin
Additionally, women may be more prone to certain GI symptoms like bloating and acid reflux, especially in the early weeks of treatment
You expect to be a sweaty mess when youre working out, but what about when youre sitting in an all-staff meeting
They are distinct drug classes with different mechanisms, efficacy, and safety profiles
